Echocardiographic Manifestations in COVID-19: A Review

Link to article at PubMed

Heart Lung Circ. 2021 Feb 19:S1443-9506(21)00050-0. doi: 10.1016/j.hlc.2021.02.004. Online ahead of print.


COVID-19 has rapidly spread around the world and threatened global health. Although this disease mainly affects the respiratory system, there is increasing evidence that SARS-CoV-2 also has effects on the cardiovascular system. Echocardiography is a valuable tool in the assessment of cardiovascular disease. It is cost-effective, widely available and provides information that can influence management. Given the risk of personnel infection and equipment contamination during echocardiography, leading world societies have recommended performing echocardiography only when a clinical benefit is likely, favouring focussed evaluations and using smaller portable equipment. In the past months, multiple reports have described a wide pattern of echocardiographic abnormalities in patients with COVID-19. This review summarises these findings and discusses the possible mechanisms involved.

PMID:33715970 | DOI:10.1016/j.hlc.2021.02.004

Leave a Reply

Your email address will not be published.